Retroviral vector targeting to melanoma cells by single-chain antibody incorporation in envelope

Human Gene Therapy
F MartinM Collins

Abstract

Two strategies for targeting recombinant retroviruses to melanoma cells were compared. One was to extend the tropism of an ecotropic envelope to human melanoma cells, the other was to enhance the tropism of an amphotropic envelope for melanoma cells. Chimeric retroviral envelopes, incorporating a single-chain antibody (ScFv) directed against high-molecular-weight melanoma-associated antigen (HMWMAA) at the amino terminus are correctly processed and incorporated into virions. ScFv-ecotropic envelope chimeras allow specific, but low-titer, targeting of HMWMAA-positive cells, when co-expressed with ecotropic envelopes. ScFv-amphotropic envelope chimeras bind specifically to HMWMAA-positive cells and allow preferential infection at high titer.

References

Oct 1, 1990·The Journal of Experimental Medicine·B GansbacherE Gilboa
Dec 1, 1988·Japanese Journal of Cancer Research : Gann·C SugiuraH Kobayashi
Feb 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·H M Yang, R A Reisfeld
Nov 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·K TanakaG Jay
Feb 1, 1994·The Journal of Experimental Medicine·L ChenK E Hellström
Oct 10, 1995·Proceedings of the National Academy of Sciences of the United States of America·X HanY W Kan
Aug 1, 1995·Proceedings of the National Academy of Sciences of the United States of America·N V SomiaI M Verma
Jan 1, 1994·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·R M BlaeseK Culver
Oct 1, 1995·Journal of Virology·F L CossetS J Russell
Feb 1, 1995·Journal of Virology·J L BattiniJ M Heard
Dec 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·G J NabelA E Chang
Jan 4, 1994·Proceedings of the National Academy of Sciences of the United States of America·D G MillerA D Miller
Jun 25, 1996·Proceedings of the National Academy of Sciences of the United States of America·A L RakhmilevichN S Yang
Oct 10, 1996·Gene·T J ReterinkM R Daha
May 1, 1994·Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology·J R Bender

❮ Previous
Next ❯

Citations

May 18, 2000·Reviews in Medical Virology·G PalùM Pizzato
Mar 30, 2000·The Journal of Gene Medicine·S J Russell, F L Cosset
Oct 18, 2001·Current Opinion in Biotechnology·D LavilletteF L Cosset
Aug 16, 2002·Transplant Immunology·D ChenJ S Bromberg
Jul 7, 2001·Human Gene Therapy·E M GordonF L Hall
Mar 27, 2001·Protein Science : a Publication of the Protein Society·S Gleiter, H Lilie
Jan 13, 2000·Protein Science : a Publication of the Protein Society·S GleiterH Lilie
Jan 11, 2013·Advances in Virology·Yoshinao KuboNaoki Yamamoto
May 21, 2005·Biotechnology Progress·Delfi KrishnaJoseph M Le Doux
Dec 1, 2001·Expert Opinion on Biological Therapy·S PandyaV Planelles
Dec 7, 2006·Virology Journal·Thomas M HowardSuraiya Rasheed
May 30, 2001·Japanese Journal of Cancer Research : Gann·S AkasakaT Shimada
May 20, 2006·PLoS Pathogens·Aliza G LloydLubbertus C F Mulder
Jan 8, 1999·Journal of Molecular Biology·M P ChadwickS J Russell
Apr 26, 2001·Molecular Therapy : the Journal of the American Society of Gene Therapy·C HughesD Darling
May 23, 2001·Leukemia·V F Van TendelooZ N Berneman
Jul 10, 1999·Journal of Virology·F MartinM Collins

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.